121 related articles for article (PubMed ID: 21491618)
21. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
[TBL] [Abstract][Full Text] [Related]
22. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.
Oetting WS; Witkop CJ; Brown SA; Colomer R; Fryer JP; Bloom KE; King RA
Am J Hum Genet; 1993 Jan; 52(1):17-23. PubMed ID: 8434585
[TBL] [Abstract][Full Text] [Related]
23. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
Oetting WS; Fryer JP; King RA
Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
[TBL] [Abstract][Full Text] [Related]
24. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
Oetting WS; Fryer JP; King RA
Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
[No Abstract] [Full Text] [Related]
25. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
Giebel LB; Spritz RA
Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
[No Abstract] [Full Text] [Related]
26. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
Oetting WS; Mentink MM; Summers CG; Lewis RA; White JG; King RA
Am J Hum Genet; 1991 Jul; 49(1):199-206. PubMed ID: 1905879
[TBL] [Abstract][Full Text] [Related]
27. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
Oetting WS
Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
[TBL] [Abstract][Full Text] [Related]
28. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
[TBL] [Abstract][Full Text] [Related]
29. Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.
Wang T; Waters CT; Jakins T; Yates JR; Trump D; Bradshaw K; Moore AT
Br J Ophthalmol; 2005 Oct; 89(10):1383-4. PubMed ID: 16170149
[No Abstract] [Full Text] [Related]
30. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
31. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
[TBL] [Abstract][Full Text] [Related]
32. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
Giebel LB; Musarella MA; Spritz RA
J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
[TBL] [Abstract][Full Text] [Related]
33. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
[TBL] [Abstract][Full Text] [Related]
34. A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2).
Kato A; Fukai K; Oiso N; Hosomi N; Saitoh S; Wada T; Shimizu H; Ishii M
J Dermatol Sci; 2003 May; 31(3):189-92. PubMed ID: 12727022
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the genes for oculocutaneous albinism type 1 and type 4 in the German population.
Zühlke C; Criée C; Gemoll T; Schillinger T; Kaesmann-Kellner B
Pigment Cell Res; 2007 Jun; 20(3):225-7. PubMed ID: 17516931
[No Abstract] [Full Text] [Related]
36. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.
Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K
Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708
[TBL] [Abstract][Full Text] [Related]
37. [Oculocutaneous albinism 1B associated with a new mutation in the TYR gene].
Vidal-Ríos P; Fernández-Seara MJ; Cortés E; Hurtado L; Couce ML
An Pediatr (Barc); 2013 May; 78(5):339-40. PubMed ID: 23085315
[No Abstract] [Full Text] [Related]
38. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
39. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
[TBL] [Abstract][Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: OCA2. Disease: albinism, oculocutaneous II.
Ray K; Sengupta M
Hum Genet; 2010 Apr; 127(4):487-8. PubMed ID: 21491617
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
